SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
Dyne Therapeutics, Inc.
@DYN_InsiderForm 4 Filing: Rhodes Jason P Sells $17.9M of $DYN
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Dyne Therapeutics, Inc.
Ticker: $DYN
Transaction Value
$17.9M
Price/Share: $22.97
transaction date
2026-07-06
Shares: 777,451
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rhodes Jason P, holds the title of Director at Dyne Therapeutics, Inc..
On 2026-07-06, the insider transacted 777,451 shares.The shares were transacted at a weighted average price of $22.97 per share, resulting in a total market-relevant value of $17.9M.
Executive Summary Summary
Rhodes Jason P (Director) sold $17.9M of $DYN
Post-Transaction Position: 4,223,448 shares
SEC Accession No: 0001577014-26-000014 (CIK: 1577014)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.